 Detection micrometastatic tumor cells bone marrow breast carcinoma patients incidence clinical significance micrometastases bone marrow breast carcinoma patients immunoalkaline phosphatase anticytokeratin antiepithelial antibodies bone marrow aspirates stage IV disease patients recurrent regional distant metastases tumor cells bone marrow patients assay significant correlation patient age menopausal status bone scan bone marrow core histology response induction chemotherapy number metastatic sites dominant site metastasis subsequent clinical outcome clinical parameters improved survival dominant site metastatic disease regional soft tissue recurrence distant disease